'Exciting' new genetic test for child cancer patients
It is hoped this will give younger patients access to newer, more personalised medicines and further improve survival rates.
News
Launch of EMA’s Priority Medicines Scheme (PRIME)
A major step forward for patients and their families that have long been hoping for earlier access to safe treatments for their unmet medical needs
Rare Disease Day: Rare Cancers & Rare Diseases: mapping similarities & difference to improve collaboration
A report highlighting the similarities and differences between patients affected by rare diseases and by rare cancers, or rare diseases leading to cancers
European Reference Networks: Rare Cancers or Forgotten Cancers?
A call for appropriate categorisation of European Reference Networks
SIOPE marks International Childhood Cancer Day
SIOPE's Strategic Plan for a Better Future for Children with Cancer
Daily Telegraph: We need to think about how we fund children's cancer
The perception that research should be funded according to incidence means that individual rare cancers are doomed forever to receive a fraction of the money
FDA approves first drug to show survival benefit in liposarcoma
The FDA approved Halaven for the treatment of liposarcoma that cannot be removed by surgery (unresectable) or is advanced (metastatic).
Submit your poster: The European Conference on Rare Diseases & Orphan Products
Submit your poster before 31/1 to ECRD 2016, taking place from 26 to 28 May 2016 in Edinburgh, Scotland
Novel Test Offers Diagnostic and Disease Monitoring Potential for Rare Childhood Brain Cancer
The test could enable clinicians to monitor treatment effectiveness without exposing patients to repeated doses of radiation.
Baxalta in deal to develop immuno-oncology drugs to treat rare cancers
Baxalta and Symphogen said they expect to conduct the first early-stage study in 2017.
New brain cancer treatment twice as effective
A new three-pronged therapy to treat some of the most aggressive malignant brain tumours is twice as effective than current treatments, researchers from UOW have found.